BREAKING: SA's new #Mpox death - the 2nd in the country - died on Wed, 12 June, the same day on which he tested positive for Mpox, says @heatlhza. The man, 38, was admitted with extensive skin lesions, a headache and sore throat.
Interested in learning about Tropical Diseases and Hygiene? Come join our @WitsDTMH diploma course at @WitsHealthFac. There is still time to register. Fully online!
Please help spread the word...
More info on the course at https://t.co/J2Wj300tpr
@Microbedoc2 Keyhole effect. ESBL producer.
Also seen when CZA disc near mero or imi and the carbapenemase susceptible to avibactam and between CZA and Aztreonam if it's an NDM (+- an ESBL)
So.....there is a Zaficefta (cetazidime-avibactam) shortage, just in time for the festive season. Are you getting same report from pharmacists? @JamesWesleyMac1@microbemail@Nonku54635540
@JamesWesleyMac1@microbemail Wonder if change in antibiotic exposure with intro of CZA, driving carbapenmase evolution. Can we just get Aztreonam-avibactam already....but then who knows what crazy changes will happen
@JamesWesleyMac1@microbemail Purely anecdotal, before these three in 2 weeks (different hospitals, molecular confident no contamination), before that saw only 2 in 18months. In terms of NDM1 and dual OXA48+NDM1, we have similar results. The rest is OXA-48 only.
See these carba and CZA resistant, aztreonam susceptible isolates occasionally. Test either NDM1 or NDM1+OXA48 positive. Would you treat with ATM? (if was avaiable) or still add CZA for avi for a sneaky ESBL? ATM is relatively stable against OXA48 @JamesWesleyMac1@microbemail
@JamesWesleyMac1@microbemail@Anja2heart See this too. Have no idea where comes from, even after doing a lit search. Some paeds withhold feeds or base neonatal treatment (even if improving on narrow empiric therapy) on results, even if advise otherwise. ?legacy practice. ?extrapolation from breast milk bank screening
@Ashka_TxID Low resource setting here. OXA-48+NDM1 not infrequent. If can access we go CZA+ATM after proven "synergy" testing, if no other option. Theory: Avibactam inhibits ESBL +-OXA48. ATM resistant to NDM hydrolysis and CAZ & ATM relatively resistant to OXA48 hydrolysis. No access 2 CFDC